| IRIC | Incident Reporting & Investigation Centre |
| Reporting | Learning | Prevention | |
Circulation
DL1 NHS Incidents and alerts Safety Officers
DL3 Specialist Liaison Group
DL4 Product Specialists
DL7 General list (external)
National Procurement NP16722, NP16923
| Outlook tags | IRICSW$i0 (safety alert – general), IRICSW$i8 (MHRA safety guidance) |
| Reference: | July 2026, V5.0.0 |
| Subject: | Safety Guidelines for Magnetic Resonance Imaging Equipment in Clinical Use |
MHRA has published the attached safety guidance document and it applies across the UK. Within Scotland, the guidance applies to NHS boards and independent healthcare contractors providing publicly funded health and social care services.
A PDF version of the guidance is attached. You can also view a web version on the MHRA website.
Onward distribution
As the nominated person for your organisation, you are responsible for ensuring that this information is forwarded to the managers and staff who need to be aware of it or take action in response to it.
Enquiries
Enquiries relating to specific equipment or products referenced in the alert should be directed to the manufacturer or supplier (please refer to the attached alert for relevant contact details and instructions).
If you have a query about IRIC safety alerts generally, please contact nss.iric@nhs.scot, quoting the alert reference number.
If you received this message via a colleague within your own organisation, please direct enquiries to them in the first instance. They can then liaise with IRIC as required, helping to maintain local communication and governance arrangements.
Incident Reporting & Investigation Centre (IRIC)
Public Services Delivery Scotland
Gyle Square | 1 South Gyle Crescent
Edinburgh | EH12 9EB
m: 0131 275 7575
FAC406-272, 8B(ii), Rev 4
——————————————————————————————————————————————————–
This email is intended for the named recipient only. If you have received it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from your system; .
and (iii) do not copy the email or disclose its contents to anyone.
——————————————————————————————————————————————————–